Published Date:2023-08-31 Original Link:https://www.onenessbio.com/en/news_detail241_2.htm No 1 Date of announcement 2023/08/31 Time of announcement  21:42:45 Subject Oneness has submitted a 510(k) application to the U.S. FDA to expand the intended patient population and add multiple chronic wound indications for Bonvadis. To which item it meets paragraph 10 Date of events 2023/08/31 Statement Product: Bonvadis for wound...Read More